Multimodal lifestyle intervention consistently improves cognition in early dementia

For patients with early Alzheimer's disease and mild cognitive impairment, cognition is consistently improved with multimodal lifestyle interventions (MMLIs), while monoclonal antibodies (MABs) clear amyloid plaques but only modestly preserve cognition, according to research presented at the annual